CRC
IMMU

Curi RMB Capital’s Immunomedics Inc IMMU Stock Holding History

Curi RMB Capital’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-107,640
Closed -$2.28M – 817
2019
Q4 		$2.28M Sell
107,640
-25,552
-19% -$451K 0.06% 257
2019
Q3 		$1.77M Sell
133,192
-45,515
-25% -$669K 0.05% 319
2019
Q2 		$2.48M Buy
178,707
+30,028
+20% +$452K 0.06% 278
2019
Q1 		$2.86M Buy
148,679
+88,286
+146% +$1.42M 0.07% 278
2018
Q4 		$862K Buy
+60,393
New +$1.2M 0.02% 527

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Curi RMB Capital's IMMU Position: Q1 2020 in Review

Curi RMB Capital sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 107,640 shares — an estimated $2.28M sold.

Curi RMB Capital first reported a position in IMMU in Q4 2018 and held it in 5 quarters. The position peaked at $2.86M in Q1 2019. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

  • Curi RMB Capital reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
  • Curi RMB Capital sold 107,640 Immunomedics Inc shares in Q1 2020, an estimated $2.28M.
  • Curi RMB Capital first reported a position in Immunomedics Inc in Q4 2018 and held it in 5 quarters.
  • Curi RMB Capital's Immunomedics Inc position peaked at $2.86M in Q1 2019.
  • 220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Curi RMB Capital's 13F filing for Q1 2020, filed 11 May 2020.